If a member of your family is diagnosed with breast cancer, leukemia, lymphoma or another cancer, it will help you to know that biotechnology has enabled therapies over the past 20 years that are working miracles. A growing percentage of cancer patients are surviving and returning to good health thanks to these biotechnology breakthroughs.

Some diseases are more likely to strike the women in your family. Rheumatoid arthritis is a good example; the disease afflicts two million people – mostly women – often during early or middle adulthood. Today, biotechnology drugs that slow the painful, joint-destroying progression of the disease are helping tens of thousands of women.

These improvements in health care for you and your family are just a small sample of the benefits biotechnology has brought – and will continue to bring in the future. New products in advanced testing or under consideration for approval at the FDA include medications for osteoporosis, psoriasis, lupus, stroke, HIV, sickle-cell disease, cystic fibrosis, and rare genetic diseases.

65 East Wacker Place Suite 1600, Chicago, IL 60601 P: 312.422.1111 F: 312.422.1145
The Institute is a not-for-profit corporation and is tax-exempt as a public charity under Sections 501(c)(3) and 509 of the Internal Revenue Code.